Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3701
Aldeyra Therapeutics
ALDX
$91.1M
| $207K | ﹤0.01% |
29,779
+20,844
| +233% | +$119K |
|
|
UDMY
3702
DELISTED
Udemy
UDMY
| $207K | ﹤0.01% |
19,609
+1,549
| +9% | +$20.9K |
|
|
FSRX
3703
DELISTED
FinServ Acquisition Corp. II Class A Common Stock
FSRX
| $207K | ﹤0.01% |
20,574
| – | – |
|
3704
AEON Biopharma
AEON
$12.9M
| $207K | ﹤0.01% |
286
| – | – |
|
3705
Spectrum Brands
SPB
$2.05B
| $207K | ﹤0.01% |
3,393
-13,079
| -79% | -$659K |
|
3706
DXP Enterprises
DXPE
$2.49B
| $206K | ﹤0.01% |
7,480
+2,519
| +51% | +$67K |
|
3707
CryoPort
CYRX
$769M
| $206K | ﹤0.01% |
11,868
+6,234
| +111% | +$131K |
|
|
PLL
3708
DELISTED
Piedmont Lithium
PLL
| $205K | ﹤0.01% |
4,663
+2,326
| +100% | +$129K |
|
3709
International Money Express
IMXI
$372M
| $205K | ﹤0.01% |
8,413
-22,904
| -73% | -$526K |
|
3710
First Advantage
FA
$3.48B
| $205K | ﹤0.01% |
15,768
+9,562
| +154% | +$125K |
|
3711
Gran Tierra Energy
GTE
$241M
| $205K | ﹤0.01% |
20,700
+3,450
| +20% | +$40.6K |
|
|
PFHD
3712
DELISTED
Professional Holding Corp. Class A Common stock
PFHD
| $205K | ﹤0.01% |
7,373
+2,925
| +66% | +$81.2K |
|
3713
Sweetgreen
SG
$714M
| $204K | ﹤0.01% |
23,828
+20,112
| +541% | +$293K |
|
|
ATRI
3714
DELISTED
Atrion Corp
ATRI
| $204K | ﹤0.01% |
365
+307
| +529% | +$185K |
|
3715
OneSpan
OSPN
$586M
| $204K | ﹤0.01% |
18,233
+8,914
| +96% | +$102K |
|
|
LICY
3716
DELISTED
Li-Cycle Holdings Corp.
LICY
| $204K | ﹤0.01% |
5,347
+4,623
| +639% | +$208K |
|
|
HHLA
3717
DELISTED
HH&L Acquisition Co.
HHLA
| $202K | ﹤0.01% |
20,000
| – | – |
|
3718
Spectral AI
MDAI
$50.9M
| $202K | ﹤0.01% |
20,000
| – | – |
|
|
AGS
3719
DELISTED
PlayAGS
AGS
| $201K | ﹤0.01% |
39,435
+16,551
| +72% | +$93.3K |
|
|
ITIC
3720
Investors Title Co
ITIC
$549M
| $201K | ﹤0.01% |
1,363
+331
| +32% | +$48.1K |
|
3721
National Healthcare
NHC
$3.49B
| $201K | ﹤0.01% |
3,378
+2,845
| +534% | +$172K |
|
3722
First Northwest Bancorp
FNWB
$108M
| $200K | ﹤0.01% |
13,051
-575
| -4% | -$8.69K |
|
3723
Genesis Energy
GEL
$1.85B
| $200K | ﹤0.01% |
19,634
-5,140
| -21% | -$52.9K |
|
3724
Security National Financial
SNFCA
$249M
| $200K | ﹤0.01% |
33,335
-116
| -0.3% | -$620 |
|
|
CCV
3725
DELISTED
Churchill Capital Corp V
CCV
| $200K | ﹤0.01% |
20,127
| – | – |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 798 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 798 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.